ACADIA Pharmaceuticals launches powder formulation of Rett syndrome drug
Go back to ACADIA Pharmaceuticals launches powder formulation of Rett syndrome drug| Acadia Pharmaceuticals, Inc. (NASDAQ: ACAD) | Delayed: 21.19 -0.06 (0.28%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $21.25 | 52 Week High | $42.49 | |||
| Open | $21.12 | 52 Week Low | $16.64 | |||
| Day High | $21.28 | P/E | N/A | |||
| Day Low | $20.92 | EPS | $-0.42 | |||
| Volume | 193,157 | |||||
